Ioannidis and Blackburn and Levin, 4 research papers very early on outlining very low ‘near zero’ infection fatality rate (IFR) e.g. children (mortality); so why did we lock down & suffer our people?

Study 1:

SOURCE:

https://www.medrxiv.org/content/10.1101/2020.07.23.20160895v4.full.pdf
‘The estimated IFR is close to zero for children and younger adults but rises exponentially with age, reaching 0.4% at age 55, 1.3% at age 65, 4.5% at age 75, and 15% at age 85. We find that differences in the age structure of the population and the age-specific prevalence of COVID-19 explain 90% of the geographical variation in population IFR.’
Study 2:

SOURCE:
https://pubmed.ncbi.nlm.nih.gov/33716331/
‘In people younger than 70 years, infection fatality rates ranged from 0.00% to 0.31% with crude and corrected medians of 0.05%.’
Study 3:

SOURCE:
https://www.acpjournals.org/doi/10.7326/M20-5352
‘The overall noninstitutionalized IFR was 0.26%. In order of magnitude, the demographic-stratified IFR varied most by age, race, ethnicity, and sex (Table). Persons younger than 40 years had an IFR of 0.01%’.
Study 4:

SOURCE:
https://www.sciencedirect.com/science/article/pii/S001393512201982X
“For 29 countries (24 high-income, 5 others), publicly available age-stratified COVID-19 death data and age-stratified seroprevalence information were available and were included in the primary analysis. The IFRs had a median of 0.034% (interquartile range (IQR) 0.013–0.056%) for the 0–59 years old population, and 0.095% (IQR 0.036–0.119%) for the 0–69 years old. The median IFR was 0.0003% at 0–19 years, 0.002% at 20–29 years, 0.011% at 30–39 years, 0.035% at 40–49 years, 0.123% at 50–59 years, and 0.506% at 60–69 years…Including data from another 9 countries with imputed age distribution of COVID-19 deaths yielded median IFR of 0.025–0.032% for 0–59 years and 0.063–0.082% for 0–69 years. Meta-regression analyses also suggested global IFR of 0.03% and 0.07%, respectively in these age groups. The current analysis suggests a much lower pre-vaccination IFR in non-elderly populations than previously suggested.”

Go to Dr Alexancer on Substack
Author: Dr. Paul Alexander